Diabetes is one of the most fatal and vastly heritable metabolic disorders across the globe primarily due to the associated long-term effects including uncontrolled blood sugar levels, blindness, renal and cardiac problems. One of the diabetes related genes peroxisome proliferated activated receptor gamma 2 (PPARg2) plays significant role in insulin metabolism and is expressed predominantly in adipose tissues. Single nucleotide polymorphism (SNPs) like Pro12Ala, is known to be associated with PPARg2 gene. In this study, we have made an effort to investigate the prevalence of Pro12Ala allele in the diabetic population of Guwahati, Assam. A total of 50 human subjects with control subjects were included in the study. The data obtained revealed that 49 out of 50 samples carried the Pro/Pro allele, while 1 individual carried the Pro/Ala allele. Results obtained in the study indicate the existence of insignificant link between the targeted SNP Pro12Ala and type 2 diabetes in the sampled population, whereas in contrast we found a strong association of the SNP Pro12Pro with diabetes. The present study shows that there is a need to carry out an extensive study with a large population, which would give us the better picture of occurrence of this SNP in Northeast Indian population.
Introduction
In the present scenario diabetes is the most prevalent and highly heritable disorder globally. The World Health Organization (WHO) came to a decision of establishing World Congress in India, primarily because one diabetic person out of four globally, is Indian. According to the WHO projections, the 30 million to 33 million diabetic patients in India will shoot up to 40 million by 2010 and 74 million by 2025. 1 WHO has declared a forewarning in 2012 that India will be the diabetes capital of the world by 2025. 2 In both, type 1 and type 2 diabetes, blood sugar levels, blood pressure and blood fats must be well monitored to prevent possible development of blindness, renal failure, and cardiac complications. 3, 4 Several genes have been found to be related to type 2 diabetes like TCF7L2, PPARg2, KCNJ11, CAPN10, TNFa, RRAD, IGFBP5, INSIG1 and NGFI-B, out of which PPARg2 has the most significant role to play. 5, 6 Peroxisome proliferated activated receptor gamma 2 (PPARg2) is a transcription factor that belongs to the same family of nuclear receptors like steroid and thyroid hormone receptors, 7 and is expressed predominantly in adipose tissues. Its action is triggered by certain fatty acids, prostanoids, and anti-diabetic agents like thiazolidinediones. 8 After activation, it heterodimerizes with the retinoid X receptor and binds to specific PPAR-responsive elements of DNA to facilitate transcription of several target genes. 9 The isoform PPARg1 is ex-pressed in most of the tissues, but the PPARg2 is specific for adipose tissue, where it plays a critical role in regulating adipogenesis and insulin functioning. 10 The PPARg2 gene is located on chromosome 3, and the specific isoforms are produced due to the result of alternative mRNA splicing. Quite a few genetic variants in the PPARg2 gene have been identified which include Pro115Gln, Val290Met, Pro467Leu and the highly prevalent Pro12Ala polymorphism in PPARg2. 11, 12 The Pro12Ala polymorphism is the result of a CCA-to-GCA missense mutation in codon 12 of exon B of the PPARg2. 13 Single nucleotide polymorphism (SNPs) related to PPARg2 gene have been reported on certain populations from Europe, North America and in Asia, 11, 14, 15 and SNP like Pro12Ala have been found to be well associated with PPARg2 gene.
Genome-wide association studies (GWAS) have immensely enhanced our understanding of the genetic basis of T2D. Most of the GWAS studies related to genes implicated in T2D have been reported from European, Chinese and African populations. [16] [17] [18] [19] Such GWAS studies, 20, 21 are found to be very limited in case of Indian population, though it is among the countries having the highest diabetic population, 16 the situation is more negligible for Northeast Indian population where many ethnic tribes and communities exist. In India, the occurrence of type 1 is considerably more uncommon, and only about 1/3 of type 2 diabetics are overweight. Diabetes is also beginning to appear much earlier in the lifespan of Indians, 22 meaning that chronic long-term complications are becoming more common. But in the Northeast zone of India the prevalence of such SNPs in relation to type 1 or 2 diabetes has not been reported so far. If such data are generated then it will be statistically easier to determine its distribution along with its function and characteristics in Northeast Indian population and thus, will be helpful in drug administration. The present study is a preliminary investigation to lay the foundation for GWAS studies for PPARg2 SNPs implicated to be indicative in type 2 diabetics in Northeastern population.
Materials and Methods
For the study, 2 mL of blood were collected from 50 subjects and from one control subject with assistance from Shristi Diagnostic center, Jonali, Guwahati (26.1833° N, 91.7333° E), Assam, India under the supervision of a pathologist. Blood samples from diabetic patients regularly monitoring blood glucose level in the diagnostic center were chosen for the study. The datasheet for each sample prepared included age, sex, weight, height and fasting glucose. For each patient the basal metabolic index (BMI) was calculated using the formula: BMI=weight (kg)/height (m) ( Table 1) .
DNA from blood was extracted through phenolchloroform extraction, 23 and quantified using Nanodrop Quantifier (Thermo Fisher Scientific Inc., Wilmington, DE, USA). The DNA was used as template for polymerase chain reaction (PCR) using primers designed specifically for identifying the Pro12Ala mutation. Three primers were designed for the amplification purpose of our targeted gene sequence through Primer3. The primer sequences used in the study are shown in Table 2 .
Amplifications were performed in a total reaction of 30 mL containing: 2.5 mL dNTPs (8 mM), 0.3 mL Taq DNA polymerase (5 U/mL), 3.0 mL 10 × buffer with 15 mM MgCl 2 , 2.0 mL Primer (10 mM), 2.0 mL Template DNA (50 ng/mL) and up to 30 mL H 2 O. PCR amplification was programmed to complete 30 cycles after an initial denaturation cycle for 2 min at 94°C. Each cycle consisted of a denaturation step at 94°C for 30 s, an annealing step at 44°C for 45 s and an elongation step at 72°C for 90 s. The primer extension segment was done for 7 min at 72°C in the final cycle. PCR-product of 15 mL was resolved in 1.5% agarose gel electrophoresis with 1× TAE running buffer. Of the three primers used for the study, primers TD1F and TD1R produced a reproducible amplicon. Hence, the PCR was carried out with all the samples collected with the primers TD1F and TD1R and the product was sent for capillary sequencing to Macrogen Korea (Seoul, Korea).
Results
The PCR conditions for the three sets of primers used for amplicons production are shown in Table 3 and out of these three sets the TD1F and TDIR were found to be more efficient in amplification of the DNA.
Sequence analysis
To see the distribution of this SNP in our samples we performed DNA sequencing. The amplicons upon sequencing produced sequences of readable length of 751 bp. Figure 1 shows the representative chromatogram of the control sample and the mutated case sample.
Statistical analysis
We begin our analysis with the hypothesis that there is no relationship between type 2 diabetes and obesity in the sampled population. For the sampled data, along with allelic and genotypic frequency statistical analysis was also performed to find the relation between diabetes and obesity through Chi-square test. The Chi-square test for the samples is shown in Table  4 . Association analysis of the SNP with type 2 diabetes was done by Chi-square test after adjustment for BMI. Prevalence of Pro12Ala SNP in Guwahati city As a result, we found that the critical P value (0.05) is less than the observed value (0.1<P<0.5) (Table 5) , which means that our hypothesis regarding the nonrelativeness of the obesity with type 2 diabetes is false.
Discussion and Conclusions
Several recent studies have demonstrated that PPARg2 gene is significantly related to type 2 and type 1 diabetes in humans. 24, 25 The importance of this gene, which is present in human chromosome number 3, is due to the presence of SNP Pro12Ala. Population study in Europe, Africa and some parts of Asia revealed that these SNP's may be responsible for obesity leading to type 2 diabetes. [26] [27] [28] But all the results were not affirmative. 29 In the previous studies, T2D subjects were found to possess a significantly higher frequency of the Pro12 allele risk than non-diabetic controls, thus providing a supportive role for PPARg2 in the genetic risk for type 2 diabetes in French Caucasians. 30 So, we hypothesized that diabetic population in Guwahati city is not related to obesity. The total study subjects were 50 along with a control. But out of 50 only one sample was found homozygously mutated (Pro12Pro), though 30 of them were highly obese (data not shown). By Chi-square test the P value was found to be 0.05. By sampling out 50 diabetic samples along with the control and calculating their BMI, we found that our P (0.16) value is much greater than the statistically standardized critical P value (0.05). Thus, our hypothesis became null and concluded that most of the diabetic people are obese. That means the SNP Pro12Ala which is associated with obesity has got modest but significant role in susceptibility to type 1 and type 2 diabetes. But after finding the genotypic (0.98 and 0.02) ( Table 6 ) and allelic frequency (0.98 and 0.02) of the control and the samples respectively, it is seen that the SNP Pro12Ala does not have a significant im- o n l y pact on type 2 diabetes and hence it follows HardyWeinberg's equilibrium theory. Out of 50 samples only 1 male individual was found to be mutated (CCA/GCA, BMI=31.4), so it was considered insignificant (data not shown). Thus, from the sequencing result we can say that although in some population this SNP Pro12Ala might have shown some significant association with obesity and type 2 diabetes, but within Guwahati city, it does not have any such impact. It is also possible that there might be some errors because of small sample number and random sampling. 31 So, for a better and clear understanding we need to have a large number controls as well as case samples. Thus, like in the European countries, 11, 31, 32 we were also unable to find any significant link of this SNP Pro12Ala with type 2 diabetes in Guwahati city. Our results show that the Pro12Ala polymorphism is not associated with obesity in the diabetic population of Guwahati city. The results show that 49 individuals out of 50 samples carried the Pro/Pro allele that is (C to C mutation at ID rs1801282), while 1 individual carried the Pro/Ala allele (C to G mutation at ID rs1801282). Till date, no published data are available on the distribution of the Pro/Ala SNP in the diabetic population of Assam. This study is a pilot scale attempt with a small population to understand the prevalence of the SNP in the urban diabetic population. The study was carried out with a secondary aim to elucidate if any link exists between the type 2 diabetics (BMI being an indicator) and the SNP. The results obtained indicated that there is a very insignificant link between the targeted SNP Pro12Ala and type 2 diabetes, but in contrast we found a strong association of the SNP Pro12Pro with diabetes. Hence, though the Hardy-Weinberg's equilibrium theory is not violated, owing to small dataset affirmative conclusion cannot be drawn from the study. However, the results obtained in the study provide the preliminary overview and emphasize the need to have an extensive analysis with a large dataset containing diabetics as well as non-diabetic population. Such a study would provide in depth analysis and will help to elucidate the frequency of existence of this SNP in Northeast India. As Northeast India is hub of many ethnic communities and tribes, understanding this polymorphism may help us in enhanced diagnosis, prevention, and therapeutic approaches toward a more systematic management of type 2 diabetes in different communities. 
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